Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Other Non-Current Assets: 2013-2025

Historic Other Non-Current Assets for Aytu Biopharma (AYTU) over the last 12 years, with Jun 2025 value amounting to $1.2 million.

  • Aytu Biopharma's Other Non-Current Assets fell 52.36% to $939,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $939,000, marking a year-over-year decrease of 52.36%. This contributed to the annual value of $1.2 million for FY2025, which is 44.90% down from last year.
  • Per Aytu Biopharma's latest filing, its Other Non-Current Assets stood at $1.2 million for FY2025, which was down 44.90% from $2.2 million recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Other Non-Current Assets ranged from a high of $2.5 million in FY2023 and a low of $465,000 during FY2021.
  • For the 3-year period, Aytu Biopharma's Other Non-Current Assets averaged around $2.0 million, with its median value being $2.2 million (2024).
  • Per our database at Business Quant, Aytu Biopharma's Other Non-Current Assets spiked by 1,309.09% in 2021 and then crashed by 44.90% in 2025.
  • Over the past 5 years, Aytu Biopharma's Other Non-Current Assets (Yearly) stood at $465,000 in 2021, then surged by 64.73% to $766,000 in 2022, then skyrocketed by 232.25% to $2.5 million in 2023, then decreased by 14.15% to $2.2 million in 2024, then crashed by 44.90% to $1.2 million in 2025.